Amino Acid and Acylcarnitine Profiles in Premature Neonates
Status: | Archived |
---|---|
Conditions: | Women's Studies |
Therapuetic Areas: | Reproductive |
Healthy: | No |
Age Range: | Any |
Updated: | 7/1/2011 |
Start Date: | April 2009 |
End Date: | April 2011 |
How Illness and Nutritional Support Influence Amino Acid and Acylcarnitine Profiles in Premature Neonates
Primary Hypotheses of the study include:
- Metabolic profiles are influenced by gestational age, chronological age, type and
degree of nutritional support and illness
- Metabolic profiles differ between neonates who receive commercial formula and neonates
who receive primarily human breast milk
- Neonates who develop parenteral associated cholestasis have metabolic markers that
identify at risk patients (high serum urea nitrogen, citrulline, histidine, methionine,
and succinyl carnitine and low thyroxine, serine and glutamate)
- Neonates that have hypothyroidism have abnormal metabolic profiles (low tyrosine
levels)
Malnutrition is a common problem in the neonatal intensive care unit. Recent studies
indicate that prematurely born neonates commonly develop a severe nutritional deficit during
the first weeks after birth, referred to as extrauterine growth restriction. Despite an
increase in growth during the second month of hospitalization, many neonates are ultimately
discharged home having grown inadequately. The early nutritional deficit affects weight gain
as well as growth in length and head circumference. Aggressive administration of parenteral
amino acids to improve protein accretion rates in very preterm neonates has been supported
in the literature. Although tolerance of high dose amino acids has been described,
researchers acknowledge that sensitive tests to monitor amino acid toxicity are not readily
available in the clinical setting.
The goals of this study are:
- To better define normal amino acid and acylcarnitine values and how they change in
premature neonates
- To measure the effect nutritional support has (human breastmilk vs. formula) on amino
acid and acylcarnitines profiles
- To measure the effect of illness (parenteral nutrition associated cholestasis) on amino
acid and acylcarnitine profiles
- To better define abnormal metabolic profiles (low tyrosine levels) in neonates that
have hypothyroidism.
We found this trial at
2
sites
Memorial Hospital of South Bend Memorial Hospital of South Bend is a community-owned, not-for-profit corporation...
Click here to add this to my saved trials
McLeod Regional Medical Center McLeod Health, a regional presence and predominant healthcare organization, is dedicated...
Click here to add this to my saved trials